The proposed bill aims to enhance sentencing for certain sex offenders by allowing the court to order medroxyprogesterone acetate treatment for individuals convicted of specific offenses against victims aged twelve or younger. The bill introduces a new section to the Arkansas Code, specifically 5-4-708, which outlines the conditions under which this treatment can be mandated. For first-time offenders convicted of rape, sexual assault in the first degree, or sexual assault in the second degree, the court may impose this treatment as part of their sentence. For repeat offenders, the treatment becomes mandatory upon conviction. The bill also stipulates that a medical expert must evaluate the defendant to determine their suitability for the treatment within sixty days of sentencing.

Additionally, the bill clarifies that the Department of Corrections will be responsible for administering and monitoring the treatment, which should begin no later than one week before the defendant's release from incarceration. The court's order will specify the duration of the treatment, which can extend up to the defendant's lifetime. Importantly, the bill states that this treatment cannot replace other legal penalties, although defendants may opt for physical castration as an alternative if they provide written consent. Overall, the legislation seeks to provide a structured approach to managing sex offenders while considering public safety and rehabilitation.